| Metric | FY 2021 | Prior Q | FY 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $325M | — | $318M | — | 2.0% |
| Op. Income | $120M | — | $103M | — | 16.7% |
| Gross Margin | 92.4% | — | 82.9% | — | 9.6pp |
| Net Margin | 29.4% | — | 25.6% | — | 3.9pp |
| EPS (Diluted) | $2.68 | — | $2.81 | — | -4.6% |
| Free Cash Flow | $133M | — | $46M | — | 189.2% |
| Item | Amount |
|---|---|
| REVENUE | $325M |
| Cost of Revenue | $25M |
| GROSS PROFIT | $300M |
| R&D Expenses | $0 |
| Selling & Marketing | $3M |
| General & Administrative | $107M |
| SG&A Expenses | $110M |
| Other Expenses | $70M |
| Operating Expenses | $180M |
| Cost & Expenses | $205M |
| OPERATING INCOME | $120M |
| Interest Income | $256M |
| Interest Expense | $10M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $120M |
| Income Tax Expense | $25M |
| Net Income from Continuing Ops | $96M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $96M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $95M |
| D&A | $14M |
| EBIT | $120M |
| EBITDA | $134M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| REVENUE | $325M |
| Cost of Revenue | $25M |
| GROSS PROFIT | $300M |
| R&D Expenses | $0 |
| Selling & Marketing | $3M |
| General & Administrative | $107M |
| SG&A Expenses | $110M |
| Other Expenses | $70M |
| Operating Expenses | $180M |
| Cost & Expenses | $205M |
| OPERATING INCOME | $120M |
| Interest Income | $256M |
| Interest Expense | $10M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $120M |
| Income Tax Expense | $25M |
| Net Income from Continuing Ops | $96M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $96M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $95M |
| D&A | $14M |
| EBIT | $120M |
| EBITDA | $134M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| Net Income | $96M |
| Depreciation & Amortization | $14M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | -$5M |
| Other Non-Cash Items | $19M |
| Change in Working Capital | $16M |
| OPERATING CASH FLOW | $142M |
| Capital Expenditure | -$9M |
| Acquisitions (Net) | $209M |
| Purchases of Investments | -$1.8B |
| Sales/Maturities of Investments | $478M |
| Other Investing Activities | -$105M |
| NET CASH FROM INVESTING | -$1.3B |
| Net Debt Issuance | -$6M |
| Common Stock Repurchased | -$4M |
| Common Dividends Paid | -$22M |
| Other Financing Activities | $1.3B |
| NET CASH FROM FINANCING | $1.2B |
| FREE CASH FLOW | $133M |
| Net Change in Cash | $94M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $461M |
| Short-Term Investments | $2.6B |
| Net Receivables | $26M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $3.1B |
| PP&E (Net) | $157M |
| Goodwill | $364M |
| Intangible Assets | $18M |
| Long-Term Investments | $6.6B |
| Tax Assets | $0 |
| Other Non-Current Assets | $256M |
| TOTAL NON-CURRENT ASSETS | $7.4B |
| TOTAL ASSETS | $10.5B |
| Account Payables | $607.0K |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $9.1B |
| TOTAL CURRENT LIABILITIES | $9.1B |
| Long-Term Debt | -$2M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $134M |
| TOTAL NON-CURRENT LIABILITIES | $153M |
| TOTAL LIABILITIES | $9.3B |
| Common Stock | $723M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $533M |
| Treasury Stock | -$2M |
| Accum. Other Comp. Income | -$25M |
| Other Equity | $2M |
| TOTAL STOCKHOLDERS' EQUITY | $1.2B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.2B |
| TOTAL LIABILITIES & EQUITY | $10.5B |
| Total Debt | $20M |
| Net Debt | -$442M |